$311 Million is the total value of Endurant Capital Management LP's 88 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 110.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABT | Buy | ABBOTT LABS | $13,756,000 | +54.1% | 309,740 | +33.3% | 4.42% | +19.9% |
| BDX | Buy | BECTON DICKINSON & CO | $12,878,000 | +65.5% | 70,201 | +49.4% | 4.14% | +28.8% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $11,835,000 | – | 95,100 | +100.0% | 3.80% | – |
| DVA | Buy | DAVITA INC | $10,772,000 | +99.7% | 158,479 | +88.6% | 3.46% | +55.4% |
| AET | Buy | AETNA INC NEW | $9,927,000 | +91.3% | 77,827 | +86.0% | 3.19% | +48.9% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $9,883,000 | +16.2% | 60,256 | +13.4% | 3.18% | -9.6% |
| ANTM | Buy | ANTHEM INC | $9,277,000 | +129.6% | 56,098 | +99.6% | 2.98% | +78.7% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $8,867,000 | +395.9% | 61,100 | +272.6% | 2.85% | +285.8% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $8,844,000 | +3585.0% | 570,971 | +3456.1% | 2.84% | +2772.7% |
| CTLT | Buy | CATALENT INC | $8,250,000 | +418.5% | 291,308 | +393.7% | 2.65% | +303.8% |
| ESRX | Buy | EXPRESS SCRIPTS HLDG CO | $7,779,000 | +17.6% | 118,027 | +22.8% | 2.50% | -8.5% |
| CAH | Buy | CARDINAL HEALTH INC | $7,608,000 | +115.3% | 93,291 | +90.0% | 2.45% | +67.5% |
| PFE | Buy | PFIZER INC | $7,543,000 | +67.0% | 220,500 | +58.5% | 2.42% | +29.9% |
| VWR | New | VWR CORP | $7,233,000 | – | 256,484 | +100.0% | 2.33% | – |
| CELG | Buy | CELGENE CORP | $7,155,000 | +74.2% | 57,500 | +62.1% | 2.30% | +35.6% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $5,942,000 | +15.4% | 38,686 | +6.0% | 1.91% | -10.2% |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $5,552,000 | +66.9% | 131,700 | +52.4% | 1.78% | +29.8% |
| CVS | Buy | CVS HEALTH CORP | $4,561,000 | +24.3% | 58,100 | +24.9% | 1.47% | -3.3% |
| ZTS | New | ZOETIS INCcl a | $4,040,000 | – | 75,700 | +100.0% | 1.30% | – |
| EVHC | Buy | ENVISION HEALTHCARE CORP | $4,041,000 | +14.2% | 65,900 | +17.9% | 1.30% | -11.1% |
| AKRXQ | Buy | AKORN INC | $3,809,000 | +64.7% | 158,200 | +49.4% | 1.22% | +28.3% |
| MYL | Buy | MYLAN N V | $3,552,000 | +40.6% | 91,100 | +37.6% | 1.14% | +9.4% |
| BIIB | Buy | BIOGEN INC | $3,071,000 | +13.6% | 11,232 | +17.8% | 0.99% | -11.6% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $2,914,000 | +108.0% | 20,312 | +86.1% | 0.94% | +61.8% |
| ELGX | New | ENDOLOGIX INC | $2,425,000 | – | 335,007 | +100.0% | 0.78% | – |
| KTWO | New | K2M GROUP HLDGS INC | $2,424,000 | – | 118,200 | +100.0% | 0.78% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $2,282,000 | – | 176,100 | +100.0% | 0.73% | – |
| CRL | Buy | CHARLES RIV LABS INTL INC | $2,140,000 | +51.9% | 23,788 | +28.7% | 0.69% | +18.2% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $2,028,000 | +148.2% | 31,850 | +73.1% | 0.65% | +92.9% |
| MDT | New | MEDTRONIC PLC | $2,006,000 | – | 24,900 | +100.0% | 0.64% | – |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $2,005,000 | +101.9% | 21,316 | +101.1% | 0.64% | +57.3% |
| ILMN | New | ILLUMINA INC | $1,826,000 | – | 10,700 | +100.0% | 0.59% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $1,755,000 | – | 88,300 | +100.0% | 0.56% | – |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $1,692,000 | +94.9% | 52,733 | +120.3% | 0.54% | +51.5% |
| NVRO | Buy | NEVRO CORP | $1,688,000 | +146.8% | 18,020 | +91.3% | 0.54% | +91.9% |
| GILD | New | GILEAD SCIENCES INC | $1,494,000 | – | 22,000 | +100.0% | 0.48% | – |
| NLNK | New | NEWLINK GENETICS CORP | $1,433,000 | – | 59,444 | +100.0% | 0.46% | – |
| VREX | New | VAREX IMAGING CORP | $1,428,000 | – | 42,500 | +100.0% | 0.46% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $1,363,000 | – | 340,672 | +100.0% | 0.44% | – |
| DPLO | New | DIPLOMAT PHARMACY INC | $1,356,000 | – | 85,043 | +100.0% | 0.44% | – |
| JNJ | Buy | JOHNSON & JOHNSON | $1,258,000 | +30.0% | 10,100 | +20.2% | 0.40% | +1.0% |
| CNMD | New | CONMED CORP | $1,204,000 | – | 27,100 | +100.0% | 0.39% | – |
| ZSAN | New | ZOSANO PHARMA CORP | $1,135,000 | – | 597,180 | +100.0% | 0.36% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $1,101,000 | – | 29,600 | +100.0% | 0.35% | – |
| DERM | Buy | DERMIRA INC | $1,064,000 | +39.8% | 31,188 | +24.3% | 0.34% | +8.9% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $1,032,000 | +360.7% | 173,458 | +205.4% | 0.33% | +257.0% |
| PDCO | New | PATTERSON COMPANIES INC | $1,013,000 | – | 22,400 | +100.0% | 0.33% | – |
| TVTY | New | TIVITY HEALTH INC | $928,000 | – | 31,900 | +100.0% | 0.30% | – |
| KERX | New | KERYX BIOPHARMACEUTICALS INC | $875,000 | – | 142,100 | +100.0% | 0.28% | – |
| PRTA | New | PROTHENA CORP PLC | $815,000 | – | 14,600 | +100.0% | 0.26% | – |
| ARA | New | AMERICAN RENAL ASSOCIATES HO | $776,000 | – | 45,978 | +100.0% | 0.25% | – |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $763,000 | – | 36,700 | +100.0% | 0.24% | – |
| HUM | New | HUMANA INC | $742,000 | – | 3,600 | +100.0% | 0.24% | – |
| PKI | New | PERKINELMER INC | $673,000 | – | 11,593 | +100.0% | 0.22% | – |
| INCR | New | INC RESH HLDGS INCcl a | $514,000 | – | 11,200 | +100.0% | 0.16% | – |
| RGNX | New | REGENXBIO INC | $479,000 | – | 24,800 | +100.0% | 0.15% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $448,000 | – | 5,100 | +100.0% | 0.14% | – |
| CRVS | New | CORVUS PHARMACEUTICALS INC | $282,000 | – | 13,600 | +100.0% | 0.09% | – |
| ANAB | New | ANAPTYSBIO INC | $258,000 | – | 9,300 | +100.0% | 0.08% | – |
| XBI | New | SPDR SERIES TRUSTs&p biotech | $243,000 | – | 3,500 | +100.0% | 0.08% | – |
| VRX | New | VALEANT PHARMACEUTICALS INTL | $221,000 | – | 20,000 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.